Starpharma (ASX:SPL) awarded $1 million funding for Covid-19 spray - Sequoia Direct Pty Ltd

03SepSeptember 3, 2020

Starpharma (ASX:SPL) awarded $1 million funding for Covid-19 spray

Starpharma (ASX:SPL) has been awarded $1 million in matched funding by the Australian Government’s Medical Research Future Fund (MRFF) Biomedical Translation Bridge (BTB) Program.

The money is to expedite development and commercialisation of its Covid-19 antiviral nasal spray.

Starpharma’s product was selected for support by an expert international panel as one of only five recipients for this COVID-19 specific MRFF funding which required projects to be capable of achieving substantial and rapid impact in the global response to the COVID-19 pandemic within 12 months.

Starpharma’s patented SPL7013 nasal spray has the potential to prevent both acquisition and transmission of SARS-CoV-2 and, due to its broad-spectrum antiviral activity.

Share sin Starpharma (ASX:SPL) are trading 4.29 per cent higher at $1.70.

Copyright 2020 – Finance News Network

Source: Finance News Network

Related Posts

20MarMarch 20, 2020

Brickworks (ASX:BKW) to close five plants in Pennsylvania

20 Mar 2020 - Brickworks (ASX:BKW) is to close five of their 12 plants currently in operation in Pennsylvania after the Governor ordered all non-life-sustaining businesses to close.

23MarMarch 23, 2020

Select Harvests (ASX:SHV) says almond harvest to continue

23 Mar 2020 - Paul Thompson, Managing Director of almond business Select Harvests (ASX:SHV), has confirmed all Select Harvests’ facilities and almond harvest will continue to operate.

24MayMay 24, 2022

Snap dives 28% pulling ASX tech giants lower on rising inflation

24 May 2022 - Snap’s share price dived over 28% after an earnings miss, warning investors of a hiring slowdown with the Nasdaq futures falling 1.3% as investors fret about tech giant’s reliance on internet advertising. The news pulled Facebook-owner Meta Platforms and Google-owner Alphabet down 7 and almost 4% respectively.

20MarMarch 20, 2020

Wesfarmers (ASX:WES) report weakness in sales of apparel

20 Mar 2020 - Wesfarmers (ASX:WES) report that since the start of the calendar year, overall momentum in the Group’s retail sales has continued in line with the first half of the financial year.

08MarMarch 8, 2023

Stocks of the Hour: Sayona Mining, Evolution Energy Minerals, Tyranna Resources

08 Mar 2023 - A snapshot of the stocks on the move featuring Sayona Mining (ASX:SYA), Evolution Energy Minerals (ASX:EV1) and Tyranna Resources (ASX:TYX).

04FebFebruary 4, 2021

Pinnacle Investment’s (ASX:PNI) NPAT jumps 120% in 1H FY21

04 Feb 2021 - Pinnacle Investment Management Group's (ASX:PNI) net profit after tax attributable to shareholders is up 120 per cent to $30.3 million in the six months to December, compared to the same period for the prior year.

07FebFebruary 7, 2023

Stocks of the Hour: C29 Metals, EV Resources, Memphasys

07 Feb 2023 - A snapshot of the stocks on the move featuring C29 Metals (ASX:C29), EV Resources (ASX:EVR) and Memphasys (ASX:MEM).

22AprApril 22, 2020

SG Fleet Group (ASX:SGF) directors take 30% paycut

22 Apr 2020 - SG Fleet Group’s (ASX:SGF) Board of Directors and senior executives have reduced their pay by 30 per cent in efforts to manage the impact of COVID-19.

06AprApril 6, 2020

Origin Energy (ASX:ORG) maintains energy markets earnings guidance

04 Apr 2020 - Origin Energy (ASX:ORG) is set to maintain its financial year 2020 Energy Markets underlying EBITDA guidance of $1.4 - $1.5 billion, subject to any material increase in bad and doubtful debt provisioning.

09OctOctober 9, 2019

Respiri (ASX:RSH) CEO Mario Gattino departs

09 Oct 2019 - Respiri (ASX:RSH) CEO Mario Gattino will be leaving the medical technology company.